Issue 186 l March 2022 www.thearabhospital.com
l 2022
Publisher Arab Health Media Communication President Simon Chamma chamma @tahmag.com Mirna Khairallah mirna@tahmag.com Simon Semaan Elham Najem Editors May Atallah, Adel Abdel Karim Najib Zein, Dany Khairallah Je ie Chlela je ie@tahmag.com Rania Khalil rania@tahmag.com Wadih Chamma wadih@tahmag.com Elie Yammine elie@tahmag.com Hanna Nehme adverti ing@thearabho pital.com OFFICES T: +961 4 53 40 58 M: +961 3 60 61 00 +357 96 158661 +967 50 2971007
KSA - UAE - OMAN - TURKEY LEBANON - JORDAN - KUWAIT BAHRAIN - QATAR - EGYPT All image from hutter tock© unle provided by client . All right re erved by the HOSPITALS magazine. No part of thi publication can be reproduced in any form without prior permi ion in writting from the publi her.
l 2022
150
BEST
CHILDREN’S HOSPITALS
2022
l
NEWTOM 7G WIDE.VISION
NEW IMAGING HORIZONS. Featuring a large gantry aperture, the NewTom 7G is the most advanced CBCT device on the market. From in-depth detail to the big picture.
ULTRA-DETAILED MULTI-DIAGNOSTICS Localised analysis over the entire body. Ray2D and 3D imaging up to 90 µm, also with radiocontrast agent. Artifact reduction and movement analysis using CineX and Cine-Scout. The eXtra Functions protocol extends the field of view longitudinally to analyse anatomical structures such as the spine and limbs.
TECHNOLOGICAL EXCELLENCE High power generator (120 kV – 20kW). High-sensitivity 3D panel and innovative algorithms for volumetric reconstruction. 77 cm gantry aperture.
ERGONOMICS AND PRACTICALITY Fully motor-powered table and 10” touch-screens, front and rear. Optimised examination flow thanks to certified NNT software with processing, sharing and RIS/PACS connectivity functions.
MAXIMISING PATIENT CARE The patient lies comfortably on the table and X-ray doses are always proportioned to the patient’s build and the examination type thanks to SafeBeamtm technology.
l 2022
www.newtom.it
Issue 186 l March 2022 www.thearabhospital.com
August March June 2021 2022
186 177 179
-36-
20 8 22 10 28 2022
12 30 14
GC MARK
32
16 2022
34
2022
18
l
Multicare X Discover new ICU solution designed by nurses for nurses
67%
Decrease in force needed to turn the patient with lateral tilt
@LINETMEA l 2022
@LINETMEA
@LINET
-66-
-52-
92
96
94 BD
70
40
BD
42
98
54 56
15000
30
46
UChicago Medicine
50
36 44
60 62 66
72 82
2022
l
l 2022
2022
l
ّ ﺗﺘﻮﻗﻔﻮا ﻋﻦ اﻟﺘﻌ ّﻠﻢ ﻻ ّ ﺗﺘﻮﻗﻔﻮا ﻋﻦ ﺗﻄﻮﻳﺮ اﻟﺬات ﻻ إﺗﺎﺣﺔ ﻓﺮص رﻓﻴﻌﺔ اﻟﻤﺴﺘﻮى Bﺻﺤﺎب اﻟﻤﻬﻦ اﻟﺼﺤﻴﺔ ﺗﺴﺘﻨﺪ إﻟﻰ أﺣﺪث اﻟﺘﻄﻮرات وا-ﻧﺠﺎزات اﻟﻌﻠﻤﻴﺔ اﻟﻤﻘﺪﻣﺔ ﻟﻠﻤﺮﺿﻰ. واﻟﻄﺒﻴﺔ ،ﺑﻬﺪف إﺛﺮاء اﻟﻜﻔﺎءات وﺗﻌﺰﻳﺰ اBداء واﻟﻨﻬﻮض ﺑﻤﻌﺎﻳﻴﺮ اﻟﺮﻋﺎﻳﺔ اﻟﺼﺤﻴﺔ ّ ﻟﻤﺰﻳﺪ ﻣﻦ اﻟﻤﻌﻠﻮﻣﺎتqatar-weill.cornell.edu/continuing-professional-development/ :
l 2022
260,000
OMIM(
700
2021
300
2022
l
Master Exécutif en Management de la Santé INSCRIPTIONS EN COURS
Un programme qui vous permet de faire face aux nouveaux défis de l’environnement de la santé au Liban et au Moyen-Orient. Le Master Exécutif en Management de la Santé de l’ESA : le programme idéal pour aider les auditeurs à maîtriser le langage et les outils du management des milieux de la Santé. Son objectif est de comprendre l’évolution des contraintes pesant sur les établissements de santé, notamment en matière de : • démarche qualité (procédure de certification), • sécurité (des actes, de la prise en charge), • gestion des risques (locaux, patients, personnels), • information du patient et droit hospitalier, • optimisation de la performance, • gouvernance et pôles.
Programme intégralement animé par les meilleurs experts internationaux du secteur de la santé. 2 DIPLÔMES : • Le MEMS « Master Exécutif en Management de la Santé » de l’ESA • L’AMES « Analyse et Management des Etablissements de Santé » de l’Université de Paris, diplôme d’État. Formation en 16 mois
En partenariat avec
BBA
289 rue Clemenceau, Beyrouth, Liban, T +961 1 373 373 ext.1126 E masters@esa.edu.lb
l 2022
LEADERS DE DEMAIN www.esa.edu.lb
3
5
2022
l
l 2022
1000
2016 2015 2002
2020
2010
11 20
2022
l
Award-winning care meets humankindness. Medical breakthroughs have continued to help people live healthier lives, and we’re honored to be recognized for them. With our new rankings by U.S. News & World Report, we celebrate these advancements and the power of humankindness to provide healing for our communities in the best way. Learn more at stlukeshealth.org./bslmcinternational
l 2022
2022
27 2022
2022
27
2022
l
l 2022
2022
l
l 2022
1AsterApp 2022
30
25
2022
17 2025
2022
l
NATIONWIDE CHILDREN’S HOSPITAL WORLD-CLASS PROGRAMS. TRAILBLAZING RESEARCH. PERSONALIZED CARE. Columbus, Ohio, may feel like a world away, but our faculty, researchers and facility have earned international reputations for expertise in rare and complex conditions. Our Cardiovascular team is leading groundbreaking development of a biodegradable tissue-engineered vascular graft for children with congenital heart defects. Our multidisciplinary Center for Colorectal and Pelvic Reconstruction excels in advanced care for even the rarest congenital disorders, motility issues, fecal incontinence concerns and more, for patients in more than 60 countries. And the powerhouse team at the helm of our Neurosurgery and Neuro-Oncology programs excels in both leadership and collaboration in multinational cancer research. When you’re here, you are the center of our attention. Come to Nationwide Children’s —nothing but the best in care, in an accessible, cosmopolitan city. Reach out to our Global Patient Services team to find out why we should be your new global destination for complex care. Learn more, refer a patient or plan a trip: NationwideChildrens.org/Global-Patient-Services GlobalPatientServices@NationwideChildrens.org +1 614 362 9127 Nationwide Children’s Hospital, Columbus, Ohio – USA
l 2022 W295713
AMERICA’S SECOND
LARGEST CHILDREN’S HOSPITAL
* Based on CHA survey of utilization and financial indicators
17 5
2017
2018
.
2022
l
Product Fact Sheet
CyStain VitalCount TM
Fast, safe, sensitive: Control your production the easy way
Product picture
Sysmex Partec GmbH Arndtstraße 11 a-b 02826 Görlitz Germany www.sysmex-partec.com Sysmex Partec is an ISO 9001:2015 and EN ISO 13485:2016 certified company.
Product name CyStainTM VitalCount
Manufacturer information CyStain VitalCount is manufactured by Sysmex Partec GmbH.
Summary CyStain VitalCount is a microbial detection kit for the unspecific detection and quantification of vital microorganisms, yeast and bacteria, in fruit juice, including clear fruit juices, fruit juices with fruit pulp and highviscosity fruit juices. The kit involves manual or automated sample preparation by pipetting robots in a 96-well format. Juice samples are automatically analysed and results are automatically reported by the CyFlow™ Cube 6 V2m analyser and the CyFlow™ Robby 6 Autoloading Station.
Product Fact Sheet CyStain VitalCount
Productivity values The CyStain VitalCount Kit is an automated, cost-effective and rapid alternative to conventional plate counts. The enumeration of total viable microorganisms allows to assess the microbial burden during in-process control and final product control of any type of fruit juice. The objective and automated read-out of the results allows clear release decision with confidence in routine quality control during juice production.
Specifications Features
Description
Technology
Vital cell stain / Flow cytometry
Sample type
Fruit juice
Species type
Living bacteria and yeast cells
Limit of detection (LoD)
At least < 1000 cells/mL
Limit of blank (LoB)
At least < 500 cells/mL
Sensitivity of the method
1 organism/bottle for bacteria and yeast (after pre-incubation)
Decrease inventory / warehouse costs
Number of tests
480
Reduce human errors due to the automate procedure
Shelf-life
12 months
In-use stability
2 months
Simplified automated operation dedicated to this application
Storage temperature
2 - 8 °C
Format
96-well plate
Objective clear-cut decision due to standardised data reporting
Sample preparation time ~ 80 min for 96 samples
Key features in industrial testing Speed up product release
Highest sensitivity: 1 organism / bottle (pre-incubation necessary)
Ordering information Reagent Article number
Item
05-5029
CyStain VitalCount
Consumables and Instruments Article number
Item
04-2026
96 Well Filter Plates
04-2025
96 Well Receiver Plates
CY-S-3061R-V2m
CyFlow Cube 6 V2m
CY-S-3083-V2m
CyFlow Robby V2m Autoloading Station
Throughput (analysis time)
< 180 min 96 samples
Carry-Over
< 0.1 %
l 2022
2022
l
l 2022
.2022
2022
2021
2022
l
l 2022
2022
2022
l
RANKED AMONGST TOP 100 WORLDWIDE HIGHEST RANKED HOSPITAL IN THE MIDDLE EAST ONLY HOSPITAL RANKED IN LEBANON
l 2022
GC MARK
GC Mark
CDC
ISO(
GC MARK
OECD
GC MARK
DQS GC MARK
DQS
2022
l
l 2022
2022
l
l 2022
2022
l
ﻣـﺮﻛـﺰ ا@ﻫـﻠـﻲ ﻟﻠـﻘـﻠـﺐ
ﻣﻦ اﻟﻘﻠﺐ ،ﻓﻘﻂ ﻛﻦ ﺳﻌﻴﺪ!..
أﺟﺮى اﻟﻤﺴﺘﺸﻔﻰ ا@ﻫﻠﻲ ﻋﺪد ﻣﻦ اﻟﻌﻤﻠﻴﺎت اﻟﻨﺎﺟﺤﺔ ﻟﻠﻘﻠﺐ اﻟﻤﻔﺘﻮح. ﺟﺮاﺣﺔ اﻟﻘﻠﺐ واﻟﺼﺪر ﻫﻲ إﺟﺮاء ﺟﺮاﺣﻲ ﻟﻠﻘﻠﺐ واﻻوﻋﻴﺔ اﻟﺪﻣﻮﻳﺔ ﻫﻲ ﻋﺒﺎرة ﻋﻦ ﻣﺠﻤﻮﻋﺔ ﻣﻦ اﻟﺘﺪﺧﻼت اﻟﺠﺮاﺣﻴﺔ اﻟﺘﻰ ﺗﻬﺪف إﻟﻰ إﺻﻼح ﻣﺸﺎﻛﻞ ﻓﻲ اﻟﻘﻠﺐ )اﻟﺼﻤﺎﻣﺎت ،واﻟﺸﺮاﻳﻴﻦ اﻟﺘﺎﺟﻴﺔ ،وﻋﻀﻠﺔ اﻟﻘﻠﺐ(. ﻛﻤﺎ ﻳﺘﻢ إﺻﻼح ا4وﻋﻴﺔ اﻟﺪﻣﻮﻳﺔ)اﺻﺎﺑﺎت اﻟﺸﺮاﻳﻴﻦ و اﻻوردة(. • ﻋﻤﻠﻴﺎت اﻟﺘﺠﺴﻴﺮ اﻟﺘﺎﺟﻲ • ﻋﻤﻠﻴﺎت ﺗﻐﻴﻴﺮ و اﺻﻼح اﻟﺼﻤﺎﻣﺎت • ﻋﻤﻠﻴﺎت اﻟﺸﺮﻳﺎن ا:ﺑﻬﺮي • ﺟﺮاﺣﺔ اﻟﺘﺎﻣﻮر
ﻟﻤﺰﻳﺪ ﻣﻦ اﻟﻤﻌﻠﻮﻣﺎت ﻳﺮﺟﻰ ا:ﺗﺼﺎل ﻋﻠﻰ ا4رﻗﺎم اﻟﺘﺎﻟﻴﺔ :
٤٤٨٩٨٠٠٠أو ٤٤٨٩٨٨٨٨ رﻗﻢ اﻻﻋﻼن :
l 2022
ANGIOTENSIN II
Beta blocker
ACE inhibitors
2022
l
BD
BD
BD
Point of Care POC
HIV
l 2022
BD
BD
BD
BD
BD
Center for Safety and
Clinical Excellence
2022
l
BD
l 2022
BD
BD
BD
BD
2022
l
l 2022
29.5 25 39.5 30
1 2 3
25
BMI
2022
l
l 2022
•
•
•
•
•
•
2022
l
2002
7
2016
l 2022
600
15000
30
100 30
1 200
×2
2022
l
•
100
• US News & World
Report
•
•
EVLP
•
•
•
l 2022
200
150
•
• •
HIPEC •
1927 10
1927
633 3000
200
1200
12
2022
l
BEST
CHILDREN’S HOSPITALS •
•
•
•
•
50
• • • •
•
•
•
•
• •
5000
• •
•
• •
600
l 2022
•
• • •
3
2022
SRTR
300
2000
•
•
• 50
50
• •
SRTR
• •
1000
•
5 1 2
2022
l
l 2022
2022
l
70
2012
15
Next Generation
FDA
LUMAKRAS
l 2022
70
70
2022
l
l 2022
• • • • •
2022
l
BERI BERI
12
MALNUTRITION
l 2022
8
5
12
770
2022
l
l 2022
2022
l
l 2022
2022
l
l 2022
15
30
5
2022
l
•
•
•
•
•
l 2022
2022
l
•
• • CT
MRI
•
•
90
”.
•
•
l 2022
•
• • • • • • • •
• • • • • • •
2022
l
2030
2023
2018-
l 2022
2022
25
2022
l
2022 2022
5000
2022
2022 5000
2022
2022
2022
2022 2022 2022 2022
l 2022
2010
2022
2022
2022
FIFA
2022
2022
FIFA
2021 2022 2022
FIFA
FIFA
2022
2022
2022
FIFA
l
GPW 13(
GAVI
10
2021
500
50
l 2022
10
87
2022
l
2022
FIFA
)Tdap
2021
Tdap
10
l 2022
5
.2022
19
2022
l
l 2022
2022
2022
2024 2022
2022
l
Radiopharmaceutical Lab
3 BETA
120
2021
3
3
2016
7
PEM
l 2022
PET -CT
80%
25 80
3D PEM
2022
l
13
2011
27
2021
120
l 2022
10
2022
l
19
50
19
2022
700
l 2022
6
180
2022
l
l 2022
12 2021
2022
l
Bacterial count in routine quality control
CyStain™ BacCount
Quantify bacteria in minutes instead of days
l 2022
17 6
20
6
10
7
2022
l
•
3
• •
•
l 2022
2022
l
l 2022
30
2022
l
l 2022
FIT
40
95%
2022
l
l 2022
•
• • • •
•
•
•
•
•
2022
l
2022
l